| 
Citations
 | 
   web
Gravina, G. L., Mancini, A., Colapietro, A., Vitale, F., Vetuschi, A., Pompili, S., et al. (2017). The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models. Tumour Biol, 39(6), 1010428317695528.
toggle visibility
Liu, Y., Shen, Y., Sun, T., & Yang, W. (2017). Mechanisms regulating radiosensitivity of glioma stem cells. Neoplasma, 64(5), 655–665.
toggle visibility
Goncalves, D. P. N., Rodriguez, R. D., Kurth, T., Bray, L. J., Binner, M., Jungnickel, C., et al. (2017). Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures. Acta Biomater, 58, 12–25.
toggle visibility
Jahan, N., Lee, J. M., Shah, K., & Wakimoto, H. (2017). Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus. Int J Cancer, 141(8), 1671–1681.
toggle visibility
Yan, H., Romero-Lopez, M., Benitez, L. I., Di, K., Frieboes, H. B., Hughes, C. C. W., et al. (2017). 3D Mathematical Modeling of Glioblastoma Suggests That Transdifferentiated Vascular Endothelial Cells Mediate Resistance to Current Standard-of-Care Therapy. Cancer Res, 77(15), 4171–4184.
toggle visibility